SCHEMBL6985746

SCHEMBL6985746

Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCCN3C(=O)CCc2ccc(C#N)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.56
MEN1 O00255 4/20 0.56
ALDH1A1 P00352 3/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
NR3C1 P04150 2/20 0.54
MAPK1 P28482 1/20 0.52
MAPT P10636 4/20 0.51
TP53 P04637 3/20 0.51
PKM P14618 1/20 0.51
LMNA P02545 2/20 0.50
HTT P42858 1/20 0.50
BRD4 O60885 1/20 0.49
CREBBP Q92793 1/20 0.49
DRD2 P14416 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
DRD3 P35462 1/20 0.48
HTR6 P50406 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985865 0.91 MAPT (0.56) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6984755 0.91 TP53 (0.56) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6982759 0.91 BRD4 (0.53) KMT2AMEN1SMN1; SMN2NR3C1MAPT
SCHEMBL6985317 0.91 NR3C1 (0.58) KMT2AMEN1SMN1; SMN2NR3C1MAPT
SCHEMBL6981579 0.91 NR3C1 (0.60) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6986216 0.91 KMT2A (0.56) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6977969 0.90 NR3C1 (0.56) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6983591 0.89 BRD4 (0.50) KMT2AMEN1SMN1; SMN2NR3C1MAPT
SCHEMBL6982160 0.87 NR3C1 (0.61) KMT2AMEN1ALDH1A1SMN1; SMN2NR3C1
SCHEMBL6984851 0.87 BRD4 (0.50) KMT2AMEN1SMN1; SMN2NR3C1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed